IGG Inc

I91.F·Frankfurt·Communication Services
Compare
0.3280+0.0060 (+1.86%)today
As of Nov 5, 8:10 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.3220
Open0.3280
Day range—
52-week range0.30600.4300
Off day high0.00%
Off 52-week high−23.72%
Volume15.00K
Avg. volume (3M)316
Market cap361.32M
EPS (TTM)0.0600
Forward P/E—
P/E ratio (TTM)5.47
Dividend yield5.71% (0.0200)
Beta (5Y)1.07
Shares outstanding1.10B
Short interest—
Earnings dateAug 13, 2026
Analyst target—
Profit margin10.04%

Against its peers

Compare in full ›
I91.F 0302.HK GRVY GDEV G5EN.ST G03.F
Market cap 361.32M 520.77M 475.72M 175.76M 508.96M 712.19M
P/E (TTM) 5.5 — 8.0 2.4 22.0 54.4
Forward P/E — 0.6 — 7.2 5.2 —
Price/book 1.0 0.2 0.9 -3.4 1.1 1.1
Dividend yield 5.71% — 4.68% — 3.06% 3.82%
1-year change −25.47% −55.53% +17.99% −56.70% −31.05% −5.15%
Today +1.86% −1.18% +0.28% +10.86% +2.39% +5.43%

The closest companies by business and industry (Electronic Gaming & Multimedia). Prices may be delayed up to 15 min.

Latest news

All I91.F news ›
Morningstar··2 outletsPositive

Biohaven Enters Strategic Licensing Agreement with Ono Pharma for Extracellular IgG Degraders in Japan and Select Asian Regions, Lead Candidate BHV-1300 in Phase 3 for Graves' Disease

NEW HAVEN, Conn. and OSAKA, Japan, Oct. 8, 2026 Tova Gardin, M.D., Chief Translational Officer of Biohaven, commented, "Pairing BHV-1300 with Ono's regional development and commercial excellence gives this portfolio its strongest and…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

16mentions in 30 days
16with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance